Aleksandar Bokan

ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly

Brandon Budhram, Léon Genecand, Katarina Zeder, Andrea Baccelli et autres

https://bit.ly/425cVX6.

ca, ch, fr, us, gb, ie, de, at, es, nl (code pays fourni par la source)

ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly

Vasile Foris, Aleksandar Bokan, Katarina Zeder, Alessandra Cuomo et autres

https://bit.ly/3Yvb7VR.

ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly

Vasile Foris, Aleksandar Bokan, Katarina Zeder, Alessandra Cuomo et autres

Extract Pulmonary vascular diseases (PVD) remain a major cause of morbidity and mortality, and their complexity continues to drive both clinical and translational research. The 2024 European Respiratory Society (ERS) International Congress in Vienna offered a unique opportunity to showcase the latest …

us, at, it, fr, nl, ch (code pays fourni par la source)

The impact of the initial treatment of venous thromboembolism on the severity of chronic thromboembolic pulmonary hypertension

Aleksandar Bokan, Biljana Joves, Axel Tobias Kempa, Ahmed Ehab

Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) arises from organized thromboembolism and altered vascular remodeling. The pathogenesis of CTEPH is not fully understood, with acute venous thromboembolism (VTE) being an assumed classic risk factor, but only accounting for 1-5% of CTEPH cases in …

ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

Sarah; https://orcid.org/0000-0003-4831-2268 Cullivan, Athénaïs; https://orcid.org/0000-0001-6246-5557 Boucly, Mitja Jevnikar, Benoît Lechartier et autres

Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension are important and frequently under-recognised conditions. This article provides an overview of key highlights in pulmonary vascular diseases from the European Respiratory Society International Congress 2023. This includes insights into disease modification …

ie, ch, us, fr, nl, de, es (code pays fourni par la source)

ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

Sarah Cullivan, Athénaïs Boucly, Mitja Jevnikar, Benoît Lechartier et autres

Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension are important and frequently under-recognised conditions. This article provides an overview of key highlights in pulmonary vascular diseases from the European Respiratory Society International Congress 2023. This includes insights into disease modification …

ie, fr, gb, ch, nl, de, be, es (code pays fourni par la source)

Pattern of lung function impairment in patients suffer from chronic thromboembolic pulmonary hypertension

Aleksandar Bokan, Anna Volk, Axel Tobias Kempa, Ana Bokan et autres

Introduction. Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension characterized by obstruction of the pulmonary arteries by organized thrombi. Secondary hypoxia-mediated bronchoconstriction could be the cause of an obstructive ventilatory defect, while pulmonary infarction or right heart failure could …

Balloon pulmonary angioplasty: are we there yet? Lessons learned and unanswered questions

Mitja Jevnikar, Aleksandar Bokan, Thomas Gille, Laurent Bertoletti et autres

Evidence supporting the use of balloon pulmonary angioplasty #BPA, which has drastically changed management of non-operable chronic thromboembolic pulmonary hypertension #CTEPH, and rationale for a future multimodal approach with combined medical therapyhttps://bit.ly/3F7ccKD

fr, ch (code pays fourni par la source)

PULMONARY ENDARTERECTOMY AS A GOLDEN STANDARD IN THE TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION – CASE REPORT

Jadranka Vučićević-Trobok, Sandra Peković, Aleksandar Bokan, Marija Benić

Plućna endarterektomija je operativni zahvat koji može izlečiti bolesnika kod kojeg je nakon plućne embolije (PE) nastala hronična tromboembolijska plućna hipertenzija (CTEPH). Plućna hipertenzija (PH) je 2003. godine na III Svetskom simpozijumu o plućnoj hipertenziji u Veneciji podeljena u pet grupa. Aktuelna …

ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly

Mona Lichtblau, Lucilla Piccari, Sheila Ramjug, Aleksandar Bokan et autres

This article aims to summarise the latest research presented at the virtual 2021 European Respiratory Society (ERS) International Congress in the field of pulmonary vascular disease. In light of the current guidelines and proceedings, knowledge gaps are addressed and the newest findings …

ch, es, gb, fr, pt, il, be, nl (code pays fourni par la source)

Type of anticoagulant therapy as a risk factor for the severity of chronic thromboembolic pulmonary hypertension

Aleksandar Bokan, Gerd Staehler, Axel Tobias Kempa, Anna Volk

Introduction: In the last five years, there has been a growing trend towards the use of direct oral anticoagulants (DOACs) as a long-term anticoagulant therapy in patients who have had pulmonary embolism (PE). Vitamin K antagonists (VKAs) still remain the first-line anticoagulant …

Predictive Value of Heart Failure with Reduced versus Preserved Ejection Fraction for Outcome in Pulmonary Embolism

Slobodan D. Obradovic, Boris Džudović, Bojana Subotić, Jovan Matijašević et autres

AIMS: This study aimed to investigate whether the risk of short-term mortality is different in pulmonary embolism (PE) patients who have heart failure with reduced ejection fraction (HFrEF) as compared with those with heart failure with preserved ejection fraction (HFpEF). METHODS AND …

rs, ba, gr, de (code pays fourni par la source)